These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3266284)

  • 21. Respiratory infectivity of a recently isolated Egyptian strain of Rift Valley fever virus.
    Brown JL; Dominik JW; Morrissey RL
    Infect Immun; 1981 Sep; 33(3):848-53. PubMed ID: 7287187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogenicity and immunogenicity of a mutagen-attenuated Rift Valley fever virus immunogen in pregnant ewes.
    Morrill JC; Jennings GB; Caplen H; Turell MJ; Johnson AJ; Peters CJ
    Am J Vet Res; 1987 Jul; 48(7):1042-7. PubMed ID: 3631685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serological evidence of inter-epizootic/inter-epidemic circulation of Rift Valley fever virus in domestic cattle in Kyela and Morogoro, Tanzania.
    Matiko MK; Salekwa LP; Kasanga CJ; Kimera SI; Evander M; Nyangi WP
    PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006931. PubMed ID: 30418975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a sheep challenge model for Rift Valley fever.
    Faburay B; Gaudreault NN; Liu Q; Davis AS; Shivanna V; Sunwoo SY; Lang Y; Morozov I; Ruder M; Drolet B; Scott McVey D; Ma W; Wilson W; Richt JA
    Virology; 2016 Feb; 489():128-40. PubMed ID: 26748334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential for mosquito transmission of attenuated strains of Rift Valley fever virus.
    Turell MJ; Rossi CA
    Am J Trop Med Hyg; 1991 Mar; 44(3):278-82. PubMed ID: 2035749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attenuation and protective efficacy of Rift Valley fever phlebovirus rMP12-GM50 strain.
    Ly HJ; Nishiyama S; Lokugamage N; Smith JK; Zhang L; Perez D; Juelich TL; Freiberg AN; Ikegami T
    Vaccine; 2017 Dec; 35(48 Pt B):6634-6642. PubMed ID: 29061350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolation of Rift Valley fever virus from human peripheral blood mononuclear cells: Mauritanian epidemic.
    Sarthou JL; Jouan A; Le Guenno B; Philippe B; Riou O; Lena P; Knauert FK; Peters CJ; Digoutte JP
    Res Virol; 1989; 140(3):263-70. PubMed ID: 2667067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Recombinant Rift Valley Fever Virus Glycoprotein Subunit Vaccine Confers Full Protection against Rift Valley Fever Challenge in Sheep.
    Faburay B; Wilson WC; Gaudreault NN; Davis AS; Shivanna V; Bawa B; Sunwoo SY; Ma W; Drolet BS; Morozov I; McVey DS; Richt JA
    Sci Rep; 2016 Jun; 6():27719. PubMed ID: 27296136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of a Rift Valley fever virus vaccine against an aerosol infection in rats.
    Anderson GW; Lee JO; Anderson AO; Powell N; Mangiafico JA; Meadors G
    Vaccine; 1991 Oct; 9(10):710-4. PubMed ID: 1759489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antigenic analysis of Rift Valley fever virus isolates: monoclonal antibodies distinguish between wild-type and neurotropic virus strains.
    Besselaar TG; Blackburn NK; Meenehan GM
    Res Virol; 1991; 142(6):469-74. PubMed ID: 1803412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of a recombinant Rift Valley fever virus MP-12 with NSm deletion as a vaccine candidate in sheep.
    Weingartl HM; Nfon CK; Zhang S; Marszal P; Wilson WC; Morrill JC; Bettinger GE; Peters CJ
    Vaccine; 2014 Apr; 32(20):2345-9. PubMed ID: 24462482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A geographical information system-based multicriteria evaluation to map areas at risk for Rift Valley fever vector-borne transmission in Italy.
    Tran A; Ippoliti C; Balenghien T; Conte A; Gely M; Calistri P; Goffredo M; Baldet T; Chevalier V
    Transbound Emerg Dis; 2013 Nov; 60 Suppl 2():14-23. PubMed ID: 24589097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Rift Valley Fever and phleboviroses in the Central African Republic].
    Meunier DM; Madelon MC; Lesbordes JL; Georges AJ
    Bull Soc Pathol Exot Filiales; 1988; 81(1):49-57. PubMed ID: 3042177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experimental Infection of Calves by Two Genetically-Distinct Strains of Rift Valley Fever Virus.
    Wilson WC; Davis AS; Gaudreault NN; Faburay B; Trujillo JD; Shivanna V; Sunwoo SY; Balogh A; Endalew A; Ma W; Drolet BS; Ruder MG; Morozov I; McVey DS; Richt JA
    Viruses; 2016 May; 8(5):. PubMed ID: 27223298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rift Valley fever MP-12 vaccine Phase 2 clinical trial: Safety, immunogenicity, and genetic characterization of virus isolates.
    Pittman PR; Norris SL; Brown ES; Ranadive MV; Schibly BA; Bettinger GE; Lokugamage N; Korman L; Morrill JC; Peters CJ
    Vaccine; 2016 Jan; 34(4):523-530. PubMed ID: 26706271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Zinga virus: a strain of Rift Valley fever virus.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1983 Feb; 32(7):90-2. PubMed ID: 6403821
    [No Abstract]   [Full Text] [Related]  

  • 37. Mutation of adjacent cysteine residues in the NSs protein of Rift Valley fever virus results in loss of virulence in mice.
    Monteiro GER; Jansen van Vuren P; Wichgers Schreur PJ; Odendaal L; Clift SJ; Kortekaas J; Paweska JT
    Virus Res; 2018 Apr; 249():31-44. PubMed ID: 29530722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Laboratory safe detection of nucleocapsid protein of Rift Valley fever virus in human and animal specimens by a sandwich ELISA.
    Jansen van Vuren P; Paweska JT
    J Virol Methods; 2009 Apr; 157(1):15-24. PubMed ID: 19124041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enzyme-linked immunosorbent assay for detection of Rift Valley fever virus antigen in mosquitoes.
    Niklasson BS; Gargan TP
    Am J Trop Med Hyg; 1985 Mar; 34(2):400-5. PubMed ID: 3985279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The S segment of rift valley fever phlebovirus (Bunyaviridae) carries determinants for attenuation and virulence in mice.
    Vialat P; Billecocq A; Kohl A; Bouloy M
    J Virol; 2000 Feb; 74(3):1538-43. PubMed ID: 10627566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.